Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Josep M LlovetArndt VogelDavid C MadoffRichard S FinnSadahisa OgasawaraZhenggang RenKalgi ModyJerry J LiAbby B SiegelLeonid DubrovskyMasatoshi KudoPublished in: Cardiovascular and interventional radiology (2022)
gov NCT04246177.